Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Multiple Sclerosis

Free Subscription Articles published in Acta Neurol Scand Retrieve available abstracts of 47 articles: HTML format

Single Articles

March 2008
1. SAARI A , Tolonen U, Paakko E, Suominen K, et al
   Sympathetic skin responses in multiple sclerosis.
   Acta Neurol Scand. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. JALOSINSKI M , Karolczak K, Mazurek A, Glabinski A, et al
   The effects of methylprednisolone and mitoxantrone on CCL5-induced migration of lymphocytes in multiple sclerosis.
   Acta Neurol Scand. 2008;.
   PubMed     Related articles    Abstract available
   
   
   February 2008
3. KRHUT J , Hradilek P, Zapletalova O
   Analysis of the upper urinary tract function in multiple sclerosis patients.
   Acta Neurol Scand. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. LINDSEY JW , Patel S, Zou J
   Epstein-Barr virus genotypes in multiple sclerosis.
   Acta Neurol Scand. 2008;117:141-4.
   PubMed     Related articles    Abstract available   Free Full Text
   
   
   January 2008
5. ALONSO A , Hernan MA, Ascherio A
   Allergy, family history of autoimmune diseases, and the risk of multiple sclerosis.
   Acta Neurol Scand. 2008;117:15-20.
   PubMed     Related articles    Abstract available
   
   
   December 2007
6. BODINI B , Mandarelli G, Tomassini V, Tarsitani L, et al
   Alexithymia in multiple sclerosis: relationship with fatigue and depression.
   Acta Neurol Scand. 2007;.
   PubMed     Related articles    Abstract available
   
   
   November 2007
7. PETEREIT HF , Moeller-Hartmann W, Reske D, Rubbert A, et al
   Rituximab in a patient with multiple sclerosis - effect on B cells, plasma cells and intrathecal IgG synthesis.
   Acta Neurol Scand. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
8. ALSHUBAILI AF , Ohaeri JU, Awadalla AW, Mabrouk AA, et al
   Quality of life in multiple sclerosis: a Kuwaiti MSQOL-54 experience.
   Acta Neurol Scand. 2007;.
   PubMed     Related articles    Abstract available
   
   
   October 2007
9. MUNCH C , Meyer R, Linke P, Meyer T, et al
   The p150 subunit of dynactin (DCTN1) gene in multiple sclerosis.
   Acta Neurol Scand. 2007;116:231-4.
   PubMed     Related articles    Abstract available
   
   
   
10. GREEVE I , Sellner J, Lauterburg T, Walker U, et al
    Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort.
    Acta Neurol Scand. 2007;116:207-10.
    PubMed     Related articles    Abstract available
    
    
    
11. POSER CM , Brinar VV
    Disseminated encephalomyelitis and multiple sclerosis: two different diseases - a critical review.
    Acta Neurol Scand. 2007;116:201-6.
    PubMed     Related articles    Abstract available
    
    
    September 2007
12. GUERRERO AL , Laherran E, Gutierrez F, Martin-Polo J, et al
    Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Acta Neurol Scand. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
13. SPAIN LA , Tubridy N, Kilpatrick TJ, Adams SJ, et al
    Illness perception and health-related quality of life in multiple sclerosis.
    Acta Neurol Scand. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
14. NAESS H , Beiske AG, Myhr KM
    Quality of life among young patients with ischaemic stroke compared with patients with multiple sclerosis.
    Acta Neurol Scand. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. DRESSEL A , Mirowska-Guzel D, Gerlach C, Weber F, et al
    Migration of T-cell subsets in multiple sclerosis and the effect of interferon-beta1a.
    Acta Neurol Scand. 2007;116:164-8.
    PubMed     Related articles    Abstract available
    
    
    August 2007
16. BARTOS A , Fialova L, Soukupova J, Kukal J, et al
    Antibodies against light neurofilaments in multiple sclerosis patients.
    Acta Neurol Scand. 2007;116:100-7.
    PubMed     Related articles    Abstract available
    
    
    
17. YTTERBERG C , Johansson S, Andersson M, Olsson D, et al
    Combination therapy with interferon-beta and glatiramer acetate in multiple sclerosis.
    Acta Neurol Scand. 2007;116:96-99.
    PubMed     Related articles    Abstract available
    
    
    July 2007
18. WU X , Kuusisto H, Dastidar P, Huhtala H, et al
    Once-weekly 22microg subcutaneous IFN-beta-1a in secondary progressive MS: a 3-year follow-up study on brain MRI measurements and serum MMP-9 levels.
    Acta Neurol Scand. 2007;116:43-8.
    PubMed     Related articles    Abstract available
    
    
    June 2007
19. PAKDAMAN H , Sahraian MA, Fallah A, Pakdaman R, et al
    Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event.
    Acta Neurol Scand. 2007;115:429-31.
    PubMed     Related articles    Abstract available
    
    
    
20. SELLEBJERG F , Kristiansen TB, Wittenhagen P, Garred P, et al
    Chemokine receptor CCR5 in interferon-treated multiple sclerosis.
    Acta Neurol Scand. 2007;115:413-8.
    PubMed     Related articles    Abstract available
    
    
    
21. SCOTT TF
    Nosology of idiopathic transverse myelitis syndromes.
    Acta Neurol Scand. 2007;115:371-6.
    PubMed     Related articles    Abstract available
    
    
    May 2007
22. TERZI M , Birinci A, Cetinkaya E, Onar MK, et al
    Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis.
    Acta Neurol Scand. 2007;115:325-30.
    PubMed     Related articles    Abstract available
    
    
    
23. LI B , Dong H, Zhang J, Song X, et al
    Cerebrospinal fluid IgG profiles and oligoclonal bands in Chinese patients with multiple sclerosis.
    Acta Neurol Scand. 2007;115:319-24.
    PubMed     Related articles    Abstract available
    
    
    
24. ROBINSON-AGRAMONTE M , Reiber H, Cabrera-Gomez JA, Galvizu R, et al
    Intrathecal polyspecific immune response to neurotropic viruses in multiple sclerosis: a comparative report from Cuban patients.
    Acta Neurol Scand. 2007;115:312-8.
    PubMed     Related articles    Abstract available
    
    
    
25. ALVES-LEON SV , Papais-Alvarenga R, Magalhaes M, Alvarenga M, et al
    Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients.
    Acta Neurol Scand. 2007;115:306-11.
    PubMed     Related articles    Abstract available
    
    
    April 2007
26. HAWKES CH , Ramkumar N, Baker R, Lyon JL, et al
    Multiple sclerosis in Latter Day Saints (Mormons).
    Acta Neurol Scand. 2007;115:260-4.
    PubMed     Related articles    Abstract available
    
    
    March 2007
27. KAMALI-SARVESTANI E , Nikseresht A, Aflaki E, Sarvari J, et al
    TNF-alpha, TNF-beta and IL-4 gene polymorphisms in Iranian patients with multiple sclerosis.
    Acta Neurol Scand. 2007;115:161-6.
    PubMed     Related articles    Abstract available
    
    
    
28. ONOUE H , Satoh JI, Ogawa M, Tabunoki H, et al
    Detection of anti-Nogo receptor autoantibody in the serum of multiple sclerosis and controls.
    Acta Neurol Scand. 2007;115:153-60.
    PubMed     Related articles    Abstract available
    
    
    
29. DRULOVIC J , Pekmezovic T, Matejic B, Mesaros S, et al
    Quality of life in patients with multiple sclerosis in Serbia.
    Acta Neurol Scand. 2007;115:147-52.
    PubMed     Related articles    Abstract available
    
    
    
30. SZCZUCINSKI A , Losy J
    Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.
    Acta Neurol Scand. 2007;115:137-46.
    PubMed     Related articles    Abstract available
    
    
    January 2007
31. TSIVGOULIS G , Triantafyllou N, Papageorgiou C, Evangelopoulos ME, et al
    Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients.
    Acta Neurol Scand. 2007;115:67-72.
    PubMed     Related articles    Abstract available
    
    
    December 2006
32. LOVRECIC L , Ristic S, Starcevic-Cizmarevic N, Jazbec SS, et al
    Angiotensin-converting enzyme I/D gene polymorphism and risk of multiple sclerosis.
    Acta Neurol Scand. 2006;114:374-7.
    PubMed     Related articles    Abstract available
    
    
    
33. DRESSEL A , Kolb AK, Elitok E, Bitsch A, et al
    Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis.
    Acta Neurol Scand. 2006;114:368-73.
    PubMed     Related articles    Abstract available
    
    
    
34. HAWKES CH , Giovannoni G, Keir G, Cunnington M, et al
    Seroprevalence of herpes simplex virus type 2 in multiple sclerosis.
    Acta Neurol Scand. 2006;114:363-7.
    PubMed     Related articles    Abstract available
    
    
    October 2006
35. HEESEN C , Segal J, Reich C, Hamalainen P, et al
    Patient information on cognitive symptoms in multiple sclerosis - acceptability in relation to disease duration.
    Acta Neurol Scand. 2006;114:268-72.
    PubMed     Related articles    Abstract available
    
    
    
36. KOSEOGLU BF , Gokkaya NK, Ergun U, Inan L, et al
    Cardiopulmonary and metabolic functions, aerobic capacity, fatigue and quality of life in patients with multiple sclerosis.
    Acta Neurol Scand. 2006;114:261-7.
    PubMed     Related articles    Abstract available
    
    
    August 2006
37. AKGUL F , McLek I, Duman T, Seyfeli E, et al
    Subclinical left ventricular dysfunction in multiple sclerosis.
    Acta Neurol Scand. 2006;114:114-118.
    PubMed     Related articles    Abstract available
    
    
    
38. MOREIRA MA , Tilbery CP, Monteiro LP, Teixeira MM, et al
    Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
    Acta Neurol Scand. 2006;114:109-13.
    PubMed     Related articles    Abstract available
    
    
    
39. PFAFFENBERGER N , Pfeiffer KP, Deibl M, Hofer S, et al
    Association of factors influencing health-related quality of life in MS.
    Acta Neurol Scand. 2006;114:102-8.
    PubMed     Related articles    Abstract available
    
    
    June 2006
40. ZWIBEL HL
    Glatiramer acetate in treatment-naive and prior interferon-beta-1b-treated multiple sclerosis patients*
    Acta Neurol Scand. 2006;113:378-386.
    PubMed     Related articles    Abstract available
    
    
    
41. RAMSARANSING GS , De Keyser J
    Benign course in multiple sclerosis: a review.
    Acta Neurol Scand. 2006;113:359-69.
    PubMed     Related articles    Abstract available
    
    
    
42. BOSCHE B , Dohmen C, Impekoven P, Weber OZ, et al
    Stroke after initiation of interferon-beta treatment for relapsing-remitting disseminated white matter disease.
    Acta Neurol Scand. 2006;113:433-6.
    PubMed     Related articles    Abstract available
    
    
    May 2006
43. RESKE D
    Gender change and its impact on the course of multiple sclerosis.
    Acta Neurol Scand. 2006;113:347-9.
    PubMed     Related articles    Abstract available
    
    
    
44. ETEMADIFAR M , Janghorbani M, Shaygannejad V
    Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis.
    Acta Neurol Scand. 2006;113:283-7.
    PubMed     Related articles    Abstract available
    
    
    April 2006
45. HEINRICH A , Ahrens N, Schmidt S, Khaw AV, et al
    Immunophenotypic patterns of T-cell activation in neuroinflammatory diseases.
    Acta Neurol Scand. 2006;113:248-55.
    PubMed     Related articles    Abstract available
    
    
    
46. PATTI F , Pappalardo A, Florio C, Politi G, et al
    Effects of interferon beta-1a and -1b over time: 6-year results of an observational head-to-head study.
    Acta Neurol Scand. 2006;113:241-7.
    PubMed     Related articles    Abstract available
    
    
    March 2006
47. ELOVAARA I , Kuusisto H, Paalavuo R, Sarkijarvi S, et al
    Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation.
    Acta Neurol Scand. 2006;113:163-6.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Bernd Sebastian Kamps website.    Design: